Study | Study design | Setting | Clinical scenario | Primary intervention | Sham infusion | Sample size, n (MSCs/control) | Endpoint | Mean follow-up time points (months) | Withdrawal number, n (%) |
---|---|---|---|---|---|---|---|---|---|
Chen et al. 2004 [7] | RCT | Single-center | AMI | PCI | Yes | 69 (34/35) | LVEF, LVESV, LVEDV | 3, 6 | 0 (0) |
Chullikana et al. 2015 [10] | RCT | Multicenter | AMI | PCI | Yes | 20(10/10) | LVEF, Infarct size, Perfusion defect | 6, 24 | 4 (20) |
Gao et al. 2013 [28] | RCT | Multicenter | AMI | PCI | Yes | 43 (21/22) | LVEF, LVESV, LVEDV, WMSI, LVFS | 6, 12, 24 | 4 (9) |
Gao et al. 2015 [27] | RCT | Multicenter | AMI | PCI | Yes | 116 (58/58) | LVEF, LVESV, LVEDV, WMSI, LVFS | 1, 4, 12, 18 | 4 (3) |
Hare et al. 2009 [29] | RCT | Multicenter | AMI | PCI | Yes | 60 (39/21) | LVEF, LVESV, LVEDV | 1, 2, 3, 6, 12 | 0 (0) |
Houtgraaf et al. 2012 [12] | RCT | Single-center | AMI | PCI | No | 14 (10/4) | LVEF, Infarct size, Perfusion defect | 6 | 1 (7) |
Lee et al. 2014 [30] | RCT | Multicenter | AMI | PCI | NR | 69 (33/36) | LVEF, LVESV, LVEV, WMSI | 1, 2, 6 | 11 (16) |
Wang et al. 2014 [31] | RCT | Single-center | AMI | PCI | Yes | 58 (28/30) | LVEF | 1, 3, 6 | 3 (5) |